Abstract:A series of new ursolic acid (UA) derivatives substituted with various amino acids (AAs) or dipeptides (DP) at the C-3 position of the steroid skeleton was designed and synthesized. The compounds were obtained by the esterification of UA with the corresponding AAs. The cytotoxic activity of the synthesized conjugates was determined using the hormone-dependent breast cancer cell line MCF-7 and the triple-negative breast cancer cell line MDA. Three derivatives (l-seryloxy-, l-prolyloxy- and l-alanyl-l-isoleucyloxy-) showed micromolar IC50 values and reduced the concentrations of matrix metalloproteinases 2 and 9. Further studies revealed that for two compounds (l-seryloxy- and l-alanyl-l-isoleucyloxy-), a possible mechanism of their antiproliferative action is the activation of caspase-7 and the proapoptotic Bax protein in the apoptotic pathway. The third compound (l-prolyloxy- derivative) showed a different mechanism of action as it induced autophagy as measured by an increase in the concentrations of three autophagy markers: LC3A, LC3B, and beclin-1. This derivative also showed statistically significant inhibition of the proinflammatory cytokines TNF-α and IL-6. Finally, for all synthesized compounds, we computationally predicted their ADME properties as well as performed molecular docking to the estrogen receptor to assess their potential for further development as anticancer agents.

Synthesis of A Tetra-Deuterium-Labeled Derivative of Potent and Selective Anticancer Agent Aa005

Tuning the acyclic ether moiety of anticancer agent AA005 with conformationally constrained fragments.

A Gram-Scale Laboratory Synthesis of Annonaceous Acetogenin Mimic AA005

Potent Antitumor Mimetics of Annonaceous Acetogenins Embedded with an Aromatic Moiety in the Left Hydrocarbon Chain Part

Studies on mimicry of naturally occurring annonaceous acetogenins: non-THF analogues leading to remarkable selective cytotoxicity against human tumor cells.

Mimicry of Annonaceous Acetogenins: Enantioselective Synthesis of a (4R)-Hydroxy Analogue Having Potent Antitumor Activity

Ganoderic Acid A and Its Amide Derivatives as Potential Anti-Cancer Agents by Regulating the p53-MDM2 Pathway: Synthesis and Biological Evaluation

Synthesis and Cytotoxic Evaluation of Acylated Brefeldin A Derivatives As Potential Anticancer Agents

Design, synthesis of symmetrical bivalent mimetics of annonaceous acetogenins and their cytotoxicities.

A Structure–Activity Guided Strategy for Fluorescent Labeling of Annonaceous Acetogenin Mimetics and Their Application in Cell Biology

New Cytotoxic Annonaceous Acetogenin Mimetics Having A Nitrogen-Heterocyclic Terminal and Their Application to Cell Imaging

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

Novel N-phenyl Dichloroacetamide Derivatives As Anticancer Reagents: Design, Synthesis and Biological Evaluation.

Design, Synthesis and Biological Evaluation of N-arylphenyl-2,2-dichloroacetamide Analogues As Anti-Cancer Agents.

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Multi-substituted N-phenyl-2, 2-Dichloroacetamide Analogues As Anti-Cancer Drugs: Design, Synthesis and Biological Evaluation.

Probing the Anticancer Mechanism of (-)-ainsliatrimer A Through Diverted Total Synthesis and Bioorthogonal Ligation

Identification of Novel Bivalent Mimetics of Annonaceous Acetogenins Via a Scaffold-Hopping Strategy.

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents